Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mannkind Corp (MNKD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Detailed Research: Economic Perspectives on MannKind, Sonic Automotive, Five Prime Therapeutics, CONMED, Cohu, and FTI Consulting -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of MannKind Corporation (NASDAQ:MNKD),...

FCN : 78.85 (-0.19%)
FPRX : 11.97 (-4.39%)
COHU : 14.79 (-0.20%)
SAH : 15.85 (+3.06%)
CNMD : 80.01 (-0.93%)
MNKD : 1.53 (-4.38%)
MannKind to Present at the H.C. Wainwright Global Life Sciences Conference

MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension,...

MNKD : 1.53 (-4.38%)
MannKind Receives $12.5 Million Milestone Payment from United Therapeutics

MannKind Corporation (NASDAQ: MNKD) today announced that it achieved the first of several specified development milestones under its licensing and collaboration agreement with United Therapeutics for the...

UTHR : 103.50 (-0.78%)
MNKD : 1.53 (-4.38%)
Life Sciences Companies Adopt Veeva Nitro to Eliminate the Burden of Custom Data Warehouse Development and Maintenance

Veeva Systems (NYSE:VEEV) today announced that life sciences companies are adopting Veeva Nitro to accelerate their data warehouse projects and deliver faster insights to the...

VEEV : 136.65 (+0.08%)
KPTI : 4.86 (-2.41%)
MNKD : 1.53 (-4.38%)
MannKind to Sponsor Andretti Autosport Type 1 Diabetes Driver, Conor Daly

MannKind Corporation (Nasdaq:MNKD) announced today it is sponsoring Conor Daly as he makes his debut with the Andretti Autosport team at the 103rd Running of the Indianapolis 500 on May 26, 2019. MannKind...

MNKD : 1.53 (-4.38%)
MannKind Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 26, 2019 / MannKind Corporation (NASDAQ: ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on February 26, 2019 at 9:00 AM...

MNKD : 1.53 (-4.38%)
MannKind Presents New Scientific Data at 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019)

MannKind Corporation (Nasdaq:MNKD) today announced additional positive Afrezza clinical data to be presented in an oral presentation on Thursday, February 21, 2019 and a poster on Wednesday, February 20,...

MNKD : 1.53 (-4.38%)
MannKind Corporation Participating at Upcoming Conferences

MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension,...

MHMNF : 54.5000 (unch)
MNKD : 1.53 (-4.38%)
MannKind Corporation to Hold 2018 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2019

MannKind Corporation (Nasdaq:MNKD) will release its 2018 fourth quarter and full year financial results on Tuesday, February 26, 2019 and its management will host a conference call to discuss the financial...

MNKD : 1.53 (-4.38%)
Market Trends Toward New Normal in MannKind, IDEX, Belden, Bright Horizons Family Solutions, Masonite International, and Veritiv -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of MannKind Corporation (NASDAQ:MNKD),...

BDC : 58.63 (+0.05%)
VRTV : 28.30 (+1.69%)
IEX : 156.71 (+0.33%)
MNKD : 1.53 (-4.38%)
DOOR : 51.24 (+1.14%)
BFAM : 127.61 (-0.36%)
Biotech Stocks on the Move

HENDERSON, NV / ACCESSWIRE / January 21, 2019 / Biotech has been one of the hottest sectors this month. Investors are intrigued by the increase in M&A. Now's a great time to start researching some oversold...

TCON : 0.66 (-1.49%)
TYME : 1.48 (-5.73%)
ZIOP : 4.16 (unch)
DCTH : 0.1260 (-7.76%)
MNKD : 1.53 (-4.38%)
MannKind Announces Direct Purchase Insulin Program Providing Afrezza(R) for as low as $4 a Day

MannKind Corporation (Nasdaq:MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension,...

MNKD : 1.53 (-4.38%)
MannKind Corporation to Hold Investor Conference Call

MannKind Corporation (NASDAQ: MNKD) will host a conference call on Friday, January 4, 2019 to discuss Company developments at 9:00 AM (Eastern Time).

MNKD : 1.53 (-4.38%)
MannKind Announces Commencement of Public Offering

MannKind Corporation (Nasdaq: MNKD) (MannKind) today announced that it has commenced an underwritten public offering to issue and sell shares of its common stock and warrants to purchase shares of its...

MNKD : 1.53 (-4.38%)
Detailed Research: Economic Perspectives on Churchill Downs, Nordic American Tankers, News Corporation, Aduro Biotech, MannKind, and Crane -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Churchill Downs, Incorporated...

CHDN : 92.16 (+2.97%)
NAT : 2.15 (+0.94%)
NWS : 12.62 (+0.16%)
ADRO : 3.57 (+1.13%)
MNKD : 1.53 (-4.38%)
CR : 87.75 (-0.49%)
Is the Options Market Predicting a Spike in MannKind (MNKD) Stock?

Investors need to pay close attention to MannKind (MNKD) stock based on the movements in the options market lately.

MNKD : 1.53 (-4.38%)
MannKind and Cipla Enter an Exclusive Marketing and Distribution Agreement for Afrezza(R) in India

MannKind Corporation (Nasdaq:MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension,...

MNKD : 1.53 (-4.38%)
Free Research Reports on These Biotech Stocks -- MannKind, Marinus Pharma, Mirati Therapeutics, and OncoSec Medical

If you want a free Stock Review on MNKD, MRNS, MRTX, and ONCS sign up now at www.wallstequities.com/registration. WallStEquities.com has initiated research coverage on MannKind Corp. (NASDAQ: MNKD), Marinus...

ONCS : 0.58 (-1.69%)
MRTX : 62.76 (-0.38%)
MNKD : 1.53 (-4.38%)
MRNS : 4.45 (+3.49%)
MannKind Corporation to Hold 2018 First Quarter Financial Results Conference Call on May 9, 2018

MannKind Corporation (Nasdaq:MNKD) will release its 2018 first quarter financial results on Wednesday, May 9, 2018 and its management will host a conference call to discuss the financial results and other...

MNKD : 1.53 (-4.38%)
FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary

MannKind Corporation (Nasdaq:MNKD), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, today...

MNKD : 1.53 (-4.38%)

Van Meerten Stock Picks

Aaon - Pick of the Day
My Stock Pick of the Day is the HVAC company AAON (AAON).
AAON +0.35
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar